Drug intelligence / Profile preview

3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is an organic molecule containing a fatty acid attached to carnitine through an ester bond. It is classified as a small molecule and is not approved for any specific medical use. The mechanism of action is not well-documented.

Other names: (2R)-3-carboxy-2-(octanoyloxy)propyl]trimethylazanium((2R)-3-carboxy-2-(octanoyloxy)propyl)trimethylazaniumoctanoyl-L-carnitine (uncharged form)CHEMBL1234930CHEMBL-1234930CHEMBL 1234930DB03832DB-03832DB 03832NCGC00024679-01NCGC-00024679-01NCGC 00024679-01NS00069058NS-00069058NS 00069058

Beyond the preview

Go deeper on 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium.

Explore the full profile